ICICI Direct
ICICI Direct

@ICICI_Direct

9 Tweets 8 reads Jan 02, 2025
NIFTY to hit 28,300! Part 3 of the Market Strategy 2025 by ICICI Direct research gives our top picks to ride this wave! A 🧵.
Piramal Pharma (PIRPHA)
A pharma powerhouse, excelling in CRDMO and complex hospital generics, and well-positioned for growth in GLP-1 and ADCs.
Target Price: ₹ 320 (26% Upside)
(1/n)
KNR Constructions (KNRCON)
A leader in infrastructure and highways, boasting a ₹5,606 crore order book and a debt-free balance sheet. It’s eyeing ₹20,000 crore worth of new projects.
Target Price - ₹ 390 (24% Upside)
(2/n)
Narayana Hrudayalaya (NARHRU)
A healthcare giant expanding aggressively with a ₹3,000 crore capex plan, including a new hospital in the Cayman Islands.
Target Price - ₹ 1,600 (23% Upside)
(3/n)
Techno Electric and Engineering (TECEEC)
A leader in power infrastructure with a ₹9,726 crore order book, focusing on T&D, smart meters, and data centers.
Target Price - ₹ 1,920 (23% Upside)
(4/n)
Ramco Cements (RAMCEM)
A cement leader expanding to 30 MTPA by FY26, focusing on cost optimization and debt reduction to improve margins.
Target Price - ₹ 1,180 (22% Upside)
(5/n)
Aditya Birla Sun Life AMC (ADIAMC)
One of India’s largest AMCs, managing ₹3.8 trillion in AUM, with deep penetration into mutual funds and alternative investments.
Target Price - ₹ 985 (21% Upside)
(6/n)
Mahindra & Mahindra (MAHMAH)
The first one is India’s largest tractor maker and a force in SUVs with hits like the Thar Roxx and Scorpio-N. It’s investing ₹27,000 crore in EVs and tech, targeting 7 BEVs by 2030.
Target Price: ₹ 3,600 (18% Upside)
(7/n)
Larsen and Toubro (LARTOU)
India’s largest E&C player, with a ₹5 lakh crore order backlog and exposure to infrastructure, hydrocarbon, and defense.
Target Price - ₹ 4,262 (18% Upside)
(8/n)
🩷 & 🔄 the top thread if you found this insightful!
x.com
Feel free to share your thoughts and predictions in the comments and follow us for more such awesome updates!
Disclaimer: bit.ly

Loading suggestions...